Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Post by wrongturnon Aug 15, 2007 1:17am
402 Views
Post# 13246657

Reality Check

Reality CheckMarch 2005 Presentation: -carciogenic study to be over winter of 2007 -phase 3 trials over the winter of 2007 -new drug application filing mid 2007. August 2007 Presentation: -carciogenic study to be over winter of 2008 -phase 3 trials over at the end of 2008 -regulatory approval at the end of 2008/start of 2009. There is approximately 29 months between presentations and I estimate we've fallen behind about 14 to 15 months from the March 2005 presentation. If I estimate 2 months for every 1 month the company states it would take to complete an event, regulatory approval for psoriasis should take place in the winter of 2009.
Bullboard Posts